| SeneXta Therapeutics is a biopharmaceutical company engaged in the research and development of therapies for neurodegenerative disorders including Alzheimer’s disease (AD), cognitive impairment secondary to ischemia, and other central nervous system (CNS) disorders. The company is also focused on medicines that address a large unmet medical need to maintain healthy brain ageing as well as rehabilitation after ischemic brain injury. SeneXta is also broadening its products pipeline through licensing and acquisition. |